Vensun Pharmaceuticals

PharmaceuticalsSeries CUSvensunrx.com

Latest round

Series C

Last raised

Dec 2016

Total raised

$44M

Investors

3

About Vensun Pharmaceuticals

Vensun Pharmaceuticals, Inc.Founded in 2011, Vensun Pharmaceuticals, Inc. specializes in the development and distribution of generic pharmaceutical products.Vensun Pharmaceuticals, Inc. specializes in developing and distributing a diverse range of generic pharmaceutical prescription drugs. The company’s portfolio includes various dosage forms targeting multiple therapeutic categories, such as cardiovascular, infectious diseases, and chronic conditions. Vensun holds exclusive distribution rights for eight approved Abbreviated New Drug Application (ANDA) products and has over fifteen ANDA products pending FDA approval.Vensun Pharmaceuticals generates revenue through distributing its generic prescription drugs to healthcare entities, including pharmacies, hospitals, and wholesalers. The company operates on a business-to-business model, forming partnerships and agreements with distributors and retailers to sell its pharmaceutical products. The revenue structure typically involves transactional agreements where clients place orders for products, fulfilled at agreed-upon prices, reflecting competitive pricing strategies prevalent in the generic pharmaceutical sector.5 mn, to support the development and launch of new products, including over fifteen ANDA products awaiting FDA approval. The company aims to expand its market presence, focusing on increasing its distribution capabilities across the United States and potentially exploring new geographic regions. These initiatives are part of Vensun's strategy to enhance its product offerings and expand access to essential medications for patients.

Who invested in Vensun Pharmaceuticals

3 investors across 4 rounds

See all investors in Vensun Pharmaceuticals

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Dec 1, 2016

    Amount

    $23M

    Investors

    Locked

  2. Series B

    Dec 19, 2013

    Amount

    $5.1M

    Investors

    Locked

  3. Series B

    Oct 15, 2013

    Amount

    $11M

    Investors

    Locked

  4. Series A

    Mar 27, 2012

    Amount

    $5.7M

    Investors

    Locked

Questions about Vensun Pharmaceuticals

Who invested in Vensun Pharmaceuticals?

Vensun Pharmaceuticals has 3 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Vensun Pharmaceuticals raised?

Vensun Pharmaceuticals has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did Vensun Pharmaceuticals last raise money?

Vensun Pharmaceuticals's most recent round on record is a Series C, in Dec 2016.

What does Vensun Pharmaceuticals do?

Vensun Pharmaceuticals is a pharmaceuticals company.

Where is Vensun Pharmaceuticals headquartered?

Vensun Pharmaceuticals is headquartered in US.

Which VCs invest in companies like Vensun Pharmaceuticals?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Vensun Pharmaceuticals's stage. Their profiles are linked below.

Raising like Vensun Pharmaceuticals? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.